Michael A. Nauck, Daniel R. Quast, Jakob Wefers, & Juris J. Meier. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Elsevier.
Chicago Style (17th ed.) CitationMichael A. Nauck, Daniel R. Quast, Jakob Wefers, and Juris J. Meier. GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes - State-of-the-art. Elsevier, 2021.
MLA (9th ed.) CitationMichael A. Nauck, et al. GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes - State-of-the-art. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.